Proof The Bible Is True

The researchers behind an ambitious and far-reaching new university study on COVID-19 vaccine safety and efficacy hope to collect responses from 2.5 million people worldwide.

 

The principal investigator of the PROVES (People’s Response to COVID-19 Vaccine Efficacy and Safety) study is Aditi Bhargava, Ph.D., a professor in the department of Ob/Gyn and the Center for Reproductive Sciences at the University of California San Francisco (UCSF).

 

Bhargava, who has a background in molecular and developmental biology, was involved in the development in 1990 of one of the first PCR diagnostic kits for the detection of mycobacterium tuberculosis.

 

Her co-investigator, Sabra Inslicht, Ph.D., is also affiliated with UCSF as an associate professor practicing clinical psychology and stress research in the university’s department of psychiatry.

 

Organized as a survey, the PROVES study seeks to gather real-world data from respondents on “vaccine safety, severity of COVID illness, health outcomes, course of recovery, and mortality in vaccinated and unvaccinated controls.”

 

Read More: Researchers Seek Real-World Data From 2.5 Million People for Global COVID Vaccine Safety Study • Children’s Health Defense